FDA Seeks Public Input on Potential Market Name Change for Certain Rockfish Species

The U.S. Food and Drug Administration is issuing a Request for Information on a potential update to the acceptable market name for eighteen species of Sebastes, commonly known as rockfish. This action follows a congressional directive and aims to balance food safety, regulatory clarity, and industry interests through an evidence-based determination.

In November 2025, Public Law 119-37 was enacted, directing the FDA to engage with stakeholders regarding a potential name change for specific Sebastes species. The FDA maintains “The Seafood List,” a guide for the food industry on acceptable market names for seafood sold in interstate commerce, to ensure that labeling is accurate. Currently, the acceptable market name for the genus Sebastes is “rockfish.” However, the FDA has received inquiries from industry stakeholders requesting that the name be changed to “snapper.” The FDA has identified several critical issues for consideration before any changes are made to the acceptable market name for these rockfish species. These include issues related to scientific classification, food safety and hazard identification, and labeling and allergens concerns.  

To read more, please visit the FDA.